FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

5641004: Valproate semisodium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2154262012 Valproate semisodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2155284018 Divalproex sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3484640014 Valproate semisodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
58171000195117 valproato semisodico it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
26251000188110 sodium divalproate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
848721000172112 valproate semisodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
73241000195114 Valproat seminatrium de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
236711000195119 Valproat-Seminatrium de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Valproate semisodium Is a Product containing valproic acid (medicinal product) false Inferred relationship Some
Valproate semisodium Is a Valproate false Inferred relationship Some
Valproate semisodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Valproic acid (substance) true Inferred relationship Some
Valproate semisodium Is a Valproate true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium valproate 500mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Valproate semisodium Inferred relationship Some
Divalproex sodium 125mg capsule sprinkle The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Valproate semisodium Inferred relationship Some
Divalproex sodium 125mg tablet delayed release The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Valproate semisodium Inferred relationship Some
Divalproex sodium 250mg tablet delayed release The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Valproate semisodium Inferred relationship Some
Divalproex sodium 500mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Valproate semisodium Inferred relationship Some
Divalproex sodium 500mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Valproate semisodium Inferred relationship Some
Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Valproate semisodium Inferred relationship Some 1
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Valproate semisodium Inferred relationship Some 1
Product containing precisely valproic acid (as valproate semisodium) 125 milligram/1 each gastro-resistant oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Valproate semisodium Inferred relationship Some 1

This concept is not in any reference sets

Back to Start